Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogen (NEOG) Cash & Equivalents: 2010-2025

Historic Cash & Equivalents for Neogen (NEOG) over the last 16 years, with May 2025 value amounting to $129.0 million.

  • Neogen's Cash & Equivalents rose 15.28% to $138.9 million in Q3 2025 from the same period last year, while for Aug 2025 it was $138.9 million, marking a year-over-year increase of 15.28%. This contributed to the annual value of $129.0 million for FY2025, which is 24.39% down from last year.
  • Neogen's Cash & Equivalents amounted to $129.0 million in FY2025, which was down 24.39% from $170.6 million recorded in FY2024.
  • Neogen's 5-year Cash & Equivalents high stood at $170.6 million for FY2024, and its period low was $44.5 million during FY2022.
  • Moreover, its 3-year median value for Cash & Equivalents was $163.2 million (2023), whereas its average is $154.3 million.
  • In the last 5 years, Neogen's Cash & Equivalents crashed by 41.17% in 2022 and then surged by 267.05% in 2023.
  • Neogen's Cash & Equivalents (Yearly) stood at $75.6 million in 2021, then slumped by 41.17% to $44.5 million in 2022, then spiked by 267.05% to $163.2 million in 2023, then grew by 4.52% to $170.6 million in 2024, then declined by 24.39% to $129.0 million in 2025.